Literature DB >> 9123008

FK 506 in kidney transplantation: results of the U.S.A. randomized comparative phase III study. The FK 506 Kidney Transplant Study Group.

J Miller1, J D Pirsch, M Deierhoi, F Vincenti, R S Filo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9123008     DOI: 10.1016/s0041-1345(96)00270-9

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; J W Marsh; J McCauley; J Johnston; P Randhawa; W Irish; H A Gritsch; R Naraghi; T R Hakala; J J Fung; T E Starzl
Journal:  Transplantation       Date:  1999-02-15       Impact factor: 4.939

2.  Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature.

Authors:  R Shapiro; V P Scantlebury; M L Jordan; C Vivas; H A Gritsch; J McCauley; J J Fung; T R Hakala; R L Simmons; T E Starzl
Journal:  Transplant Proc       Date:  1997-09       Impact factor: 1.066

3.  Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials.

Authors:  G A Knoll; R C Bell
Journal:  BMJ       Date:  1999-04-24

4.  Pediatric renal transplantation under tacrolimus-based immunosuppression.

Authors:  R Shapiro; V P Scantlebury; M L Jordan; C Vivas; D Ellis; S Lombardozzi-Lane; N Gilboa; H A Gritsch; W Irish; J McCauley; J J Fung; T R Hakala; R L Simmons; T E Starzl
Journal:  Transplantation       Date:  1999-01-27       Impact factor: 4.939

5.  A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; H A Gritsch; F A Casavilla; J McCauley; J R Johnston; P Randhawa; W Irish; T R Hakala; J J Fung; T E Starzl
Journal:  J Urol       Date:  1998-12       Impact factor: 7.450

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.